S. Korea adopts AI-powered radiotherapy system Varian’s ETHOS

2022.12.01 12:57:01 | 2022.12.01 13:02:58

ETHOS [Source : Varian Medical Systems]이미지 확대

ETHOS [Source : Varian Medical Systems]

A cancer patient became the first person to have artificial intelligence (AI)-driven radiotherapy with a new Varian Ethos therapy system designed to reduce a typical 1-hour or more treatment timeslot to less than 15 minutes in South Korea.

The country’s first radiotherapy treatment by Ethos Therapy, developed by global medical device and software manufacturer Varian Medical Systems, went successful on Nov. 25, according to the company’s Korean operation and Ewha Womans University Seoul Hospital on Wednesday.

Ethos first developed in Chicago in 2019 is one of Varian’s latest solutions. It was approved by Korean health authorities last year and was first installed at Ewha Womans University Seoul Hospital in October this year.

Using the medical device is still away from the regulator’s reimbursement list in Korea, but the first-time treatment cost for the above-mentioned patient was known to be similar to that of existing radiotherapy equipment.

Varian plans to introduce three to four additional units of this system to Korea by next year for cancer patients, Brian Choi, Country Director at Varian Medical Systems Korea told Maeil Business Newspaper in a recent interview.

Ethos has brought innovation to the cancer treatment landscape with more than 60 units installed in more than 20 countries, including the United States, Britain, Australia, Denmark, and Japan.

Ethos Therapy powered by AI allows doctors to adapt to changes in normal tissue anatomy and radiation target structure on a daily basis, slashing the entire treatment planning and delivery by three quarters with significantly reduced side effects.

In 10 years, more than 50 percent of cancer patients in Korea would receive AI-based radiotherapy treatment such as Ethos, Choi projected.

Varian founded in 1948 has operated in more than 70 countries around the world and maintains its undisputed No. 1 position in cancer radiotherapy with its equipment and software exposed to 4 million patients every year. The brand entered Korea in 2012, and 65 percent of local hospitals with radiation oncology departments rely on Varian equipment, and more than 70 percent on its software.

By Kim Si-gyun and Minu Kim

[ⓒ Pulse by Maeil Business Newspaper & mk.co.kr, All rights reserved]